Items where authors include "Aslam, A."

Article

Fryer, K., Reynolds, J., Huang, Q. orcid.org/0000-0002-4865-5669 et al. (21 more authors) (2025) Development of a community research link worker role to enable culturally tailored research and empower marginalised communities to participate: the IBISES model. Research Involvement and Engagement, 11. 122.

Abani, O., Abbas, A., Abbas, F. et al. (7724 more authors) (2025) Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Linton, E. orcid.org/0000-0002-6112-4053, Mawson, R.L. orcid.org/0000-0001-6377-6197, Cory, R.J. orcid.org/0009-0001-0520-0242 et al. (7 more authors) (2025) Understanding women from ethnic minorities’ perspectives about contraception in the UK: a qualitative study using a participatory action research approach with community research link workers. BMJ Sexual & Reproductive Health, 51 (3). pp. 191-198. ISSN 2515-1991

Aslam, A. orcid.org/0000-0002-2654-4255, Walker, L., Abaho, M. et al. (16 more authors) (2025) An automation framework for clinical codelist development validated with UK data from patients with multiple long-term conditions. BMC Medical Research Methodology, 25 (1). 138. ISSN 1471-2288

Aslam, A., Walker, L., Abaho, M. et al. (16 more authors) (2025) An automation framework for clinical codelist development validated with UK data from patients with multiple long-term conditions. BMC Medical Research Methodology, 25. 138. ISSN 1471-2288

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Abuzour, A.S. orcid.org/0000-0002-4073-4346, Wilson, S.A., Woodall, A.A. et al. (22 more authors) (2024) A qualitative exploration of barriers to efficient and effective structured medication reviews in primary care: Findings from the DynAIRx study. PLOS ONE, 19 (8). e0299770. ISSN 1932-6203

Abuzour, A.S. orcid.org/0000-0002-4073-4346, Wilson, S.A., Woodall, A.A. et al. (22 more authors) (2024) A qualitative exploration of barriers to efficient and effective structured medication reviews in primary care: findings from the DynAIRx study. PLOS One, 19 (8). e0299770. ISSN 1932-6203

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Aslam, A., Rehman, A.U., Amin, N. et al. (7 more authors) (2023) To study the structural, electrical, and magnetic properties of M (M = Mg2+, Mn2+, and Cd2+) doped Cu-Ni-Co-La spinel ferrites. Materials Chemistry and Physics, 294. 127034. ISSN 0254-0584

Aslam, A., Rehman, A.U., Amin, N. et al. (9 more authors) (2022) Sol–Gel Auto-combustion Preparation of M2+  = Mg2+, Mn2+, Cd2+ Substituted M0.25Ni0.15Cu0.25Co0.35Fe2O4 Ferrites and Their Characterizations. Journal of Superconductivity and Novel Magnetism, 35 (2). pp. 473-483. ISSN 1557-1939

Aslam, A., Rehman, A.U., Amin, N. et al. (8 more authors) (2021) Lanthanum doped Zn0.5Co0.5LaxFe2 spinel ferrites synthesized via co-precipitation route to evaluate structural, vibrational, electrical, optical, dielectric, and thermoelectric properties. Journal of Physics and Chemistry of Solids, 154. 110080. ISSN 0022-3697

Aslam, A., Morley, N.A. orcid.org/0000-0002-7284-7978, Amin, N. et al. (8 more authors) (2021) Study of structural, optical and electrical properties of La3+ doped Mg0.25 Ni0.15 Cu0.25 Co0.35 Fe2-x Lax O4 spinel ferrites. Physica B: Condensed Matter, 602. 412565. ISSN 0921-4526

Rehman, A.U., Morley, N.A. orcid.org/0000-0002-7284-7978, Amin, N. et al. (10 more authors) (2020) Controllable synthesis of La3+ doped Zn0.5Co0.25Cu0.25Fe2−xLaxO4 (x = 0.0, 0.0125, 0.025, 0.0375, 0.05) nano-ferrites by sol-gel auto-combustion route. Ceramics International, 46 (18 (A)). pp. 29297-29308. ISSN 0272-8842

Preprint

Aslam, A., Walker, L., Abaho, M. et al. (16 more authors) (2024) An Automation Framework for Clinical Codelist Development Validated with UK Data from Patients with Multiple Long-term Conditions. [Preprint]